Sumitomo Dainippon traded at 2,229.50 this Friday February 6th, decreasing 89.00 or 3.84 percent since the previous trading session. Looking back, over the last four weeks, Sumitomo Dainippon lost 15.34 percent. Over the last 12 months, its price rose by 191.44 percent. Looking ahead, we forecast Sumitomo Dainippon to be priced at 2,204.43 by the end of this quarter and at 1,948.51 in one year, according to Trading Economics global macro models projections and analysts expectations.
Sumitomo Dainippon Pharma Co., Ltd., is a pharmaceutical company. The Company operates in four segments. The Japan segment manufactures and sells medical drugs. The North America segment manufactures, develops, purchases and sells ethical drugs. The China segment manufactures and sells ethical drugs through its consolidated subsidiary. The Other Overseas division is involved in the development of its products in Europe. The Company is also engaged in the manufacture, purchase, sale and supply of food materials and additives, chemical products, veterinary drugs, diagnostic products and inspection services of clinical pathology for animal, the manufacture of extracts, as well as the storage, delivery and clinical inspection of drugs.